Cell signalling: growth factors and tyrosine kinase receptors-Reference-Cited by-同舟云学术

Cell signalling: growth factors and tyrosine kinase receptors

Published:2006-02 Issue:2 Volume:8 Page:77-82
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Perona Rosario

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-006-0162-1.pdf

Reference11 articles.

1. Arribas J, Baselga J. Who will benefit from treatment against EGFR? Lancet Oncol. 2005;6(5):257–8.

2. Favoni RE, de Cupis A. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach. Pharmacol Rev. 2000;52(2): 179–206. Review.

3. Hofmann F, Garcia-Echeverría C. Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today. 2005;10(15):1041–7. Review.

4. Hui CH, Hughes TP. Strategies for the treatment of imatinib-resistant chronic myeloid leukemia. Clin Adv Hematol Oncol. 2003;1(9):538–45, 559, Review.

5. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5(5):341–54. Review.

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases;Biomedicines;2024-08-20

2. Tumor diagnosis using carbon-based quantum dots: Detection based on the hallmarks of cancer;Bioactive Materials;2024-03

3. Challenges and opportunities in cell expansion for cultivated meat;Frontiers in Nutrition;2024-02-07

4. Sulforaphane (Sul) reduces renal interstitial fibrosis (RIF) by controlling the inflammation and TGF-β/Smad signaling pathway;Applied Biological Chemistry;2024-01-24

5. Basic and Translational Science in Oncology;Tata Memorial Centre Textbook of Oncology;2024